-
Active Ingredient：Adrenaline
-
Content Specification：1mg per 1mL single dose
-
Pharmaceutical Form：Sterile clear injection solution
-
Applicable Standard：International pharmacopoeia specification, hospital emergency grade
-
Storage Condition：Sealed, cool and dry place, protected from light
-
Product Features：Standard emergency fixed-dose packaging, rapid onset, stable efficacy, suitable for long-term emergency reserve and clinical first-aid batch use
Package:
Product Description
- Product Name：Adrenaline Injection
- Specification：1mg/1mL
- Therapeutic Category：Emergency Resuscitation Drugs / Adrenergic Agonists
- Core Product Positioning：First-line emergency rescue medication for critical clinical scenarios
- Indicated For：Cardiac arrest, severe anaphylaxis, acute bronchospasm, hypotensive crisis and critical emergency resuscitation
- Usage Scenario：Emergency department, ICU, operating room, first aid rescue and pre-hospital emergency treatment
- Applicable Clients：Global medical institutions, emergency rescue centers, hospital procurement departments and professional pharmaceutical distributors
Product Overview
Adrenaline Injection 1mg/1mL is a classic first-line adrenergic agonist for clinical emergency rescue. It acts on both α and β adrenergic receptors, rapidly stimulating heart contraction, dilating bronchial tubes, relieving severe allergic reactions and restoring vital signs in critical patients.
Adrenaline Injection 1mg/1mL: What the Published Guidance Says
The resuscitation, antidote and critical-care injectables that a functioning emergency department cannot run without — most of them named directly on the WHO Model List.
This page collects the supply-relevant facts for Adrenaline Injection 1mg/1mL — specification, testing, packaging and the registration paperwork that travels with the batch.
- Anaphylaxis and acute allergy The Model List places epinephrine (adrenaline) among the medicines used in anaphylaxis, and carries dexamethasone injection 4 mg/mL in 1 mL ampoule as disodium phosphate salt for both antiallergic use and palliative care, as well as in the antiemetic section. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Dexamethasone is a multi-role hospital injectable Beyond allergy, the Model List carries dexamethasone injection in the antiemetic section, where it appears alongside metoclopramide and ondansetron. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
- Pre-operative and emergency antimuscarinics Atropine appears twice on the Model List — as a pre-operative medication at 400 micrograms/mL and 1 mg/mL (sulfate) in 1 mL ampoule or vial, and among specific antidotes. WHO Model List of Essential Medicines, 24th List (2025) — report of the 25th WHO Expert Committee (TRS 1064)
These points are quoted because they shape how Adrenaline Injection 1mg/1mL is specified, labelled and purchased — including strength selection, pack size and the artwork wording. Confirm each one against the approved product information in your market before finalising a purchase order.
Adrenaline Injection 1mg/1mL — Supply Parameters
| Therapeutic group | Emergency & Critical Care — Emergency & Critical Care |
| Manufacturer | Sinophare Bio-technology Co., Ltd. (GMP, China) |
| Documentation supplied | COA, HPLC/GC data, stability data, dossier package |
The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: Nimodipine Injection 10mg/50ml, Heparin Sodium Injection 2mL:5000IU, Citicoline Injection 2ml:250mg Ampoule, Aceglutamide Injection 100mg/5mL, Dobutamine Injection 12.5mg/mL 2mL, Diphenhydramine Injection 50mg/mL 2mL, Dexamethasone Injection 8mg/2mL, Acetylcysteine Injection 1g/5mL.
Quality Control, Pharmacopoeial Standards & Documentation
Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.
Adrenaline Injection 1mg/1mL is released against the pharmacopoeial monograph named on your order (USP, EP, BP or CP). Where no monograph exists for the exact presentation, the specification is agreed with you in writing before manufacture and is attached to the certificate of analysis.
Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.
A typical release panel for this presentation covers:
- Testing for related substances and impurities
- Testing for dissolution or release profile (solid oral forms)
- Testing for uniformity of dosage units
- Testing for water content and pH where applicable
- Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)
- Testing for microbial limits and preservative efficacy (multi-dose presentations)
COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.
Packaging, Labelling & Export
- Shelf life: 36 months (unopened). Stability data for the marketed pack is included in the dossier.
- Labelling: artwork can be produced in English, Arabic, French, Russian and Spanish, with your own brand and language mix, subject to the labelling rules of the destination market.
- Export: GMP certificate, COA, certificate of origin, packing list and, where required, the free-sale or marketing authorisation certificate from the country of manufacture.
Registration, Dossier & Tender Support
Sinophare Bio-technology Co., Ltd. holds DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. That registration identifies the legal manufacturer on the certificate of analysis, the GMP certificate and the documents filed with your national medicines authority.
- Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
- Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
- Batch manufacturing and packaging records released for inspection on request during supplier audits.
- Re-test or renewal support when the marketing authorisation comes up for variation or renewal.
- CTD dossier modules 1–5 in editable and PDF form, with the finished-product and API sections cross-referenced.
This page describes Adrenaline Injection 1mg/1mL as a product of the emergency and critical-care injectables named in the WHO Model List family. A WHO or national listing is a supply-context fact, not an approval in your market; marketing authorisation remains specific to each country.
Frequently Asked Questions
How is Adrenaline Injection 1mg/1mL packaged?
Injection presentations are quoted to your pack specification, with the artwork, pack size and labelling language confirmed before manufacture.
What documentation comes with a shipment of Adrenaline Injection 1mg/1mL?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months.
Does the batch documentation for Adrenaline Injection 1mg/1mL support a registration filing?
Each batch ships with a certificate of analysis covering description, identification, assay and related substances, plus stability data for the marketed pack and the GMP certificate of the manufacturing site. Shelf life: 36 months. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.
Which of these emergency medicines are on the WHO Model List?
Epinephrine (adrenaline), atropine, dexamethasone injection, calcium gluconate, acetylcysteine, furosemide and heparin appear on the Model List. Confirm current listing for every molecule against the Model List and your national essential medicines list.
Do you supply acetylcysteine as the paracetamol antidote?
Yes. Acetylcysteine injection is available for paracetamol overdose management; the Model List names acetylcysteine among specific antidotes.
Related Emergency & Critical Care Products
- Nimodipine Injection 10mg/50ml — 10mg
- Heparin Sodium Injection 2mL:5000IU — 5000IU
- Citicoline Injection 2ml:250mg Ampoule — 250mg/2mL
- Aceglutamide Injection 100mg/5mL — 100mg/5mL
- Dobutamine Injection 12.5mg/mL 2mL — 12.5mg/mL
- Diphenhydramine Injection 50mg/mL 2mL — 50mg/mL
Browse the full Emergency & Critical Care range; all Injectables; the complete product catalogue.
Request a Quotation for Adrenaline Injection 1mg/1mL
Send the specification, pack size, quantity and destination market for Adrenaline Injection 1mg/1mL 1mg and we will confirm availability, lead time and documentation. Tender quantities and registration samples are handled on the same quotation.
Sources & Regulatory Notes
Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.
